Rothwell Investment Advisors, LLC’s Biogen BIIB Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$56.9K	Buy	+252	New	+$53.5K	0.03%	400

Other funds holding BIIB

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Rothwell Investment Advisors, LLC's BIIB Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Biogen (BIIB) in Q3 2026: 252 shares worth $56.9K. The stake represents 0.03% of the portfolio and ranks #400 among its holdings.

532 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Rothwell Investment Advisors, LLC held 252 shares of Biogen worth $56.9K as of Q3 2026.
Biogen was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Biogen made up 0.03% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #400 holding.
532 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.